Home » EMA to Meet Roadmap Goals Through Adaptive Licensing, Other Initiatives
EMA to Meet Roadmap Goals Through Adaptive Licensing, Other Initiatives
July 11, 2011
The European Medicines Agency (EMA) is considering three new regulatory initiatives to improve drug safety and access, including adaptive licensing — authorizing drugs sooner but with greater initial limitations.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor